Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for ADPKD Progression in Overweight/Obese Adults
NCT06582875Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Mar 2025
- Primary completion
- Jun 2029
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in autosomal dominant polycystic kidney disease (ADPKD), sponsored by University of Colorado Denver. Started Mar 2025; status: recruiting.
02
Drugs
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT06582875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06582875.